These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 2867470)

  • 1. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.
    Colucci WS; Wright RF; Braunwald E
    N Engl J Med; 1986 Jan; 314(5):290-9. PubMed ID: 2867470
    [No Abstract]   [Full Text] [Related]  

  • 2. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of inodilators.
    Dei Cas L; Metra M; Visioli O
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S60-71. PubMed ID: 2483442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some new positive inotropic agents.
    Andersson KE
    Acta Med Scand Suppl; 1986; 707():65-73. PubMed ID: 2874692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of action of positive inotropic substances].
    Godfraind T
    Ann Cardiol Angeiol (Paris); 1984; 33(4):197-201. PubMed ID: 6087713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Positive inotropic agents in heart failure. Clinico-pharmacological evidence for medical practice].
    Rohde LE; Ribeiro JP
    Arq Bras Cardiol; 1994 Dec; 63(6):537-42. PubMed ID: 7605243
    [No Abstract]   [Full Text] [Related]  

  • 7. Inotropic drugs and their mechanisms of action.
    Scholz H
    J Am Coll Cardiol; 1984 Aug; 4(2):389-97. PubMed ID: 6330195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New inotropic drugs].
    Ferrari M; Cargnelli G; Piovan D; Bova S; Padrini R
    G Ital Cardiol; 1982; 12(2):139-46. PubMed ID: 6293904
    [No Abstract]   [Full Text] [Related]  

  • 9. [Positive inotropic agents. Generalities and classification].
    Vahanian A; Le Potier J; Sergent J; Michel PL; Acar J
    Ann Med Interne (Paris); 1985; 136(3):242-6. PubMed ID: 2862822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New positive inotropic drugs in acute and chronic heart failure].
    Follath F
    Schweiz Rundsch Med Prax; 1992 May; 81(21):704-7. PubMed ID: 1351309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure.
    Morgan JP; Erny RE; Allen PD; Grossman W; Gwathmey JK
    Circulation; 1990 Feb; 81(2 Suppl):III21-32. PubMed ID: 2153479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inotropic drugs for treatment of the failing heart.
    Maskin CS; Le Jemtel TH; Sonnenblick EH
    Cardiovasc Clin; 1984; 14(3):1-17. PubMed ID: 6327040
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors.
    Lee HR; Hershberger RE; Port JD; Rasmussen R; Renlund DG; O'Connell JB; Gilbert EM; Mealey PC; Volkman K; Menlove R
    J Thorac Cardiovasc Surg; 1991 Aug; 102(2):246-58. PubMed ID: 1650867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of adrenergic and dopamine receptors.
    Goldberg LI; Rajfer SI
    Hosp Pract (Off Ed); 1985 Jun; 20(6):67-80. PubMed ID: 2861208
    [No Abstract]   [Full Text] [Related]  

  • 15. [Old and new positive inotropic drugs: problems and controversies].
    Cocco G; Strozzi C; Tasini MT; Padula A; Urso L; Rizzo A; Alfiero R
    Minerva Cardioangiol; 1984 Nov; 32(11):831-42. PubMed ID: 6152331
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phosphodiesterase inhibition as a new positive-inotropic principle].
    Hartmann A; Saeed M; Sütsch G; Bing RJ
    Dtsch Med Wochenschr; 1986 Dec; 111(51-52):1971-7. PubMed ID: 3539571
    [No Abstract]   [Full Text] [Related]  

  • 17. Receptor systems affecting force of contraction in the human heart and their alterations in chronic heart failure.
    Brodde OE; Hillemann S; Kunde K; Vogelsang M; Zerkowski HR
    J Heart Lung Transplant; 1992; 11(4 Pt 2):S164-74. PubMed ID: 1355362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of bipyridine phosphodiesterase III inhibitors.
    Honerjäger P; Nawrath H
    Eur J Anaesthesiol Suppl; 1992; 5():7-14. PubMed ID: 1600969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.
    Colucci WS; Wright RF; Braunwald E
    N Engl J Med; 1986 Feb; 314(6):349-58. PubMed ID: 2418353
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of chronic heart failure with positive inotropic agents].
    Lechat P
    Therapie; 1989; 44(6):437-45. PubMed ID: 2576155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.